Primary Coronary Intervention in Octogenarians with ST-Segment Elevation Myocardial Infarction

Leor Perl Cardiology, Rabin Medical Center, Petach Tikva, Israel Ran Kornowski Cardiology, Rabin Medical Center, Petach Tikva, Israel Hana Vaknin-Assa Cardiology, Rabin Medical Center, Petach Tikva, Israel Gabriel Greenberg Cardiology, Rabin Medical Center, Petach Tikva, Israel Abed Samara Cardiology, Rabin Medical Center, Petach Tikva, Israel Pablo Codner Cardiology, Rabin Medical Center, Petach Tikva, Israel Guy Witberg Cardiology, Rabin Medical Center, Petach Tikva, Israel Avital Porter Cardiology, Rabin Medical Center, Petach Tikva, Israel Abid Assali Cardiology, Rabin Medical Center, Petach Tikva, Israel

Introduction:

The proportion of individuals >80 years of age constitute a growing fraction of patients who present with ST-segment elevation myocardial infarction (STEMI). However, little is known regarding outcomes in these patients.

Objectives:

To evaluate 1-month and 1-year outcomes of octogenarian patients who present with an STEMI and undergo primary percutaneous coronary intervention (pPCI).

Methods: The study included 601 consecutive STEMI patients from the Rabin Medical Center prospective registry. There were 198 patients over the age of 80 and 403 aged 70-79 years. Outcomes are reported for 1 month and 1 year.

Results:

Mean age was 85±3.8 in the octogenarian group and 74±2.9 in the control group. More patients over 80 were female (44% vs. 33%, p<0.01), more had hypertension (79% vs. 66%, p<0.01) and renal failure (43% vs. 23%, p<0.01). During presentation, more octogenarians suffered from multi-vessel disease (76% vs. 65%, p<0.0) and calcified lesions (35% vs. 26%, p=0.02).

Both at 1 month and at 1 year, rates of death were higher for the octogenarians (9.6 vs. 4.7%, p=0.02 and 15.7% vs. 9.7%, p=0.03, respectively), but other outcomes, including recurrent infarction, stent thrombosis, target vessel revascularization and the sum of major adverse cardiac events were not different between the two groups.

Conclusion:

Patients over the age of 80 have similar benefit from pPCI during STEMI, albeit a higher short-term rate of death.

Leor Perl
Leor Perl
פרל








Powered by Eventact EMS